Amorsa Therapeutics Announces Notice of Allowance for US Patent Covering Deuterated Norketamine and Related Compounds – BioSpace

Amorsa Therapeutics Announces Notice of Allowance for US Patent Covering Deuterated Norketamine and Related Compounds  BioSpace

Published: Feb 14, 2019. SOUTHBOROUGH, Mass., Feb. 14, 2019 /PRNewswire/ — Amorsa Therapeutics, Inc., a neuropharmaceutical company pioneering the …